Michael G Risbano
Overview
Explore the profile of Michael G Risbano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Rivera-Lebron B, Risbano M
Ther Adv Respir Dis
. 2017 Apr;
11(6):233-244.
PMID: 28425346
Pulmonary arterial hypertension (PAH) is a progressive disease defined by an elevation in pulmonary arterial pressure that can lead to right heart failure and death. Ambrisentan is a selective endothelin...
22.
Risbano M, Kanias T, Triulzi D, Donadee C, Barge S, Badlam J, et al.
Am J Respir Crit Care Med
. 2015 Jul;
192(10):1223-33.
PMID: 26222884
Rationale: A major abnormality that characterizes the red cell "storage lesion" is increased hemolysis and reduced red cell lifespan after infusion. Low levels of intravascular hemolysis after transfusion of aged...
23.
Hunt J, Risbano M, Messenger J, Carroll J, Badesch D, Lowes B, et al.
Pulm Circ
. 2014 Jul;
4(1):103-9.
PMID: 25006425
No abstract available.
24.
Kapnadak S, Abt D, Risbano M
Pulm Circ
. 2014 Jul;
3(4):959-62.
PMID: 25006412
Malignant melanoma is the most aggressive form of skin cancer and carries a predisposition for metastasis to many different organs. Pulmonary dissemination is common, most often presenting as multiple discrete...
25.
Risbano M, Gladwin M
Handb Exp Pharmacol
. 2013 Oct;
218:315-49.
PMID: 24092346
All forms of WHO Group 1 PAH share a progressive and complex vasculopathy. At the center of this derangement lies the pulmonary vascular endothelium, which plays a crucial role in...
26.
Stamm J, Risbano M, Mathier M
Pulm Circ
. 2011 Oct;
1(2):138-59.
PMID: 22034603
There have been tremendous strides in the management of pulmonary hypertension over the past 20 years with the introduction of targeted medical therapies and overall improvements in surgical treatment options...
27.
Risbano M, Meadows C, Coldren C, Jenkins T, Edwards M, Collier D, et al.
Clin Transl Sci
. 2010 Oct;
3(5):210-8.
PMID: 20973920
Pulmonary arterial hypertension is a common and fatal complication of scleroderma that may involve inflammatory and autoimmune mechanisms. Alterations in the gene expression of peripheral blood mononuclear cells have been...
28.
Meadows C, Risbano M, Zhang L, Geraci M, Tuder R, Collier D, et al.
Chest
. 2010 Sep;
139(5):994-1002.
PMID: 20829333
Background: Growth differentiation factor (GDF)-15 is a secreted member of the transforming growth factor-β cytokine superfamily. GDF-15 levels are elevated in the serum of patients with cardiovascular diseases. We hypothesized...
29.
Gingo M, Risbano M, Russ P, Chan E
Am J Med
. 2010 Jul;
123(8):e9-e11.
PMID: 20670714
No abstract available.
30.
Risbano M, Groshong S, Schwarz M
Chest
. 2007 Nov;
132(5):1697-701.
PMID: 17998374
No abstract available.